Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury

Background Neuroinflammation following traumatic brain injury (TBI) has been shown to be associated with secondary injury development; however, how systemic inflammatory mediators affect this is not fully understood. The aim of this study was to see how systemic inflammation affects markers of neuroinflammation, if this inflammatory response had a temporal correlation between compartments and how different compartments differ in cytokine composition. Methods TBI patients recruited to a previous randomised controlled trial studying the effects of the drug anakinra (Kineret®), a human recombinant interleukin-1 receptor antagonist (rhIL1ra), were used ( n = 10 treatment arm, n = 10 control arm). Cytokine concentrations were measured in arterial and jugular venous samples twice a day, as well as in microdialysis-extracted brain extracellular fluid (ECF) following pooling every 6 h. C-reactive protein level (CRP), white blood cell count (WBC), temperature and confirmed systemic clinical infection were used as systemic markers of inflammation. Principal component analyses, linear mixed-effect models, cross-correlations and multiple factor analyses were used. Results Jugular and arterial blood held similar cytokine information content, but brain-ECF was markedly different. No clear arterial to jugular gradient could be seen. No substantial delayed temporal associations between blood and brain compartments were detected. The development of a systemic clinical infection resulted in a significant decrease of IL1-ra, G-CSF, PDGF-ABBB, MIP-1b and RANTES ( p < 0.05, respectively) in brain-ECF, even if adjusting for injury severity and demographic factors, while an increase in several cytokines could be seen in arterial blood. Conclusions Systemic inflammation, and infection in particular, alters cytokine levels with different patterns seen in brain and in blood. Cerebral inflammatory monitoring provides independent information from arterial and jugular samples, which both demonstrate similar information content. These findings could present potential new treatment options in severe TBI patients, but novel prospective trials are warranted to confirm these associations. Graphical abstract

[1]  P. Nilsson,et al.  Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood–brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study , 2020, Critical Care.

[2]  P. Pickkers,et al.  Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions. , 2020, JAMA.

[3]  H. Thompson,et al.  Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury , 2020, The Journal of head trauma rehabilitation.

[4]  A. Faden,et al.  Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function , 2020, Critical care medicine.

[5]  Young Mi Kim,et al.  Prospective research of human parechovirus and cytokines in cerebrospinal fluid of young children less than one year with sepsis-like illness: Comparison with enterovirus. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  Chenxia Liu,et al.  Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis , 2019, Neurocritical Care.

[7]  S. Shultz,et al.  Infections after a traumatic brain injury: The complex interplay between the immune and neurological systems , 2019, Brain, Behavior, and Immunity.

[8]  Wei Bi,et al.  Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice , 2019, Scientific Reports.

[9]  L. Hillered,et al.  Interleukin-6 Levels in Cerebrospinal Fluid and Plasma in Patients with Severe Spontaneous Subarachnoid Hemorrhage. , 2019, World neurosurgery.

[10]  A. Faden,et al.  Chronic Alterations in Systemic Immune Function after Traumatic Brain Injury. , 2018, Journal of neurotrauma.

[11]  H. Vatter,et al.  Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications , 2017, International journal of molecular sciences.

[12]  D. Menon,et al.  A systematic review of cerebral microdialysis and outcomes in TBI: relationships to patient functional outcome, neurophysiologic measures, and tissue outcome , 2017, Acta Neurochirurgica.

[13]  D. Menon,et al.  Cerebrospinal Fluid and Microdialysis Cytokines in Severe Traumatic Brain Injury: A Scoping Systematic Review , 2017, Front. Neurol..

[14]  S. Elsenbruch,et al.  Sex differences in the pro-inflammatory cytokine response to endotoxin unfold in vivo but not ex vivo in healthy humans , 2017, Innate immunity.

[15]  N. Rothwell,et al.  Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. , 2017, Journal of neurosurgery.

[16]  A. Easton,et al.  Human Brain Chemokine and Cytokine Expression in Sepsis: A Report of Three Cases , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[17]  J. Pickard,et al.  Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  B. Taylor,et al.  Diffuse traumatic brain injury induces prolonged immune dysregulation and potentiates hyperalgesia following a peripheral immune challenge , 2016, Molecular pain.

[19]  J. Lord,et al.  Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus , 2015, Front. Neurol..

[20]  U. Ungerstedt,et al.  Consensus statement from the 2014 International Microdialysis Forum , 2015, Intensive Care Medicine.

[21]  M. Schreiber,et al.  Clinical evidence of inflammation driving secondary brain injury: A systematic review , 2015, The journal of trauma and acute care surgery.

[22]  N. Ikuta,et al.  Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury , 2014, Brain injury.

[23]  E. Yan,et al.  Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury. , 2014, Journal of neurotrauma.

[24]  J. Pickard,et al.  Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  N. Rothwell,et al.  The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial , 2014, Journal of Neuroinflammation.

[26]  H. Perlman,et al.  Traumatic brain injury–induced alterations in peripheral immunity , 2013, The journal of trauma and acute care surgery.

[27]  S. Leib,et al.  Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis , 2013, BMC Infectious Diseases.

[28]  B. Stoica,et al.  Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states , 2013, Neurobiology of Aging.

[29]  David K. Menon,et al.  Changing patterns in the epidemiology of traumatic brain injury , 2013, Nature Reviews Neurology.

[30]  M. Morganti-Kossmann,et al.  The Role of Markers of Inflammation in Traumatic Brain Injury , 2013, Front. Neurol..

[31]  Richard E. Carson,et al.  Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates , 2012, NeuroImage.

[32]  J. Pickard,et al.  The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal Production , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  J. Hillman,et al.  Differences in Cerebral Extracellular Response of Interleukin-1β, Interleukin-6, and Interleukin-10 After Subarachnoid Hemorrhage or Severe Head Trauma in Humans , 2011, Neurosurgery.

[34]  Maren S Fragala,et al.  Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research , 2010, Current opinion in clinical nutrition and metabolic care.

[35]  V. Perry.  Contribution of systemic inflammation to chronic neurodegeneration , 2010, Acta Neuropathologica.

[36]  C. Mclean,et al.  In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. , 2010, Journal of neurotrauma.

[37]  R. MacCallum,et al.  Extended analysis of early computed tomography scans of traumatic brain injured patients and relations to outcome. , 2010, Journal of neurotrauma.

[38]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[39]  L. Acarín,et al.  Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury‐induced cytokine response after excitotoxic damage , 2009, Journal of neuroscience research.

[40]  J. Pickard,et al.  Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery. , 2009, Journal of neurotrauma.

[41]  Y. Huang,et al.  Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines , 2009, Brain, Behavior, and Immunity.

[42]  V. Perry,et al.  Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease , 2009, Biological Psychiatry.

[43]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[44]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[45]  S. Wisniewski,et al.  Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. , 2007, Journal of neurotrauma.

[46]  A. Helmy,et al.  Traumatic brain injury: intensive care management. , 2007, British journal of anaesthesia.

[47]  C. Werner,et al.  Pathophysiology of traumatic brain injury. , 2007, British journal of anaesthesia.

[48]  J. Stenken,et al.  Microdialysis sampling of cytokines. , 2006, Methods.

[49]  N. Rothwell,et al.  Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.

[50]  Sumana Chakravarty,et al.  Toll-Like Receptor 4 on Nonhematopoietic Cells Sustains CNS Inflammation during Endotoxemia, Independent of Systemic Cytokines , 2005, The Journal of Neuroscience.

[51]  N. M. Dung,et al.  Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. , 2004, The Journal of infectious diseases.

[52]  V. Perry.  The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease , 2004, Brain, Behavior, and Immunity.

[53]  M. Vitek,et al.  APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response* , 2003, Journal of Biological Chemistry.

[54]  C. Woiciechowsky,et al.  Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. , 2002, The Journal of trauma.

[55]  M. Kaminishi,et al.  Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. , 2001, Shock.

[56]  A. Schindler,et al.  Sex differences in posttraumatic cytokine release of endotoxin-stimulated whole blood: relationship to the development of severe sepsis. , 2000, The Journal of trauma.

[57]  H. Joller,et al.  IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood–brain barrier function , 1999, Journal of Neuroimmunology.

[58]  J. Pickard,et al.  Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[59]  L. Mascia,et al.  Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. , 1997, British journal of anaesthesia.

[60]  W. Haddon,et al.  The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. , 1974, The Journal of trauma.

[61]  C. Wade,et al.  Acute Inflammation in Traumatic Brain Injury and Polytrauma Patients Using Network Analysis. , 2019, Shock.

[62]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[63]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[64]  Lemstra,et al.  UvA-DARE ( Digital Academic Repository ) Cholinergic deficiency and inflammation in cognitive dysfunction , 2008 .

[65]  A. Hyder,et al.  The impact of traumatic brain injuries: a global perspective. , 2007, NeuroRehabilitation.

[66]  B. Jennett,et al.  Assessment and prognosis of coma after head injury , 2005, Acta Neurochirurgica.

[67]  J. Pagès.  Multiple Factor Analysis: Main Features and Application to Sensory Data , 2004 .

[68]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[69]  H. Joller,et al.  IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. , 1999, Journal of neuroimmunology.